DK112793D0 - Fremgangsmaade til fremstilling af krystallinsk type a botulinium toxin som et terapeutisk medikament - Google Patents
Fremgangsmaade til fremstilling af krystallinsk type a botulinium toxin som et terapeutisk medikamentInfo
- Publication number
- DK112793D0 DK112793D0 DK931127A DK112793A DK112793D0 DK 112793 D0 DK112793 D0 DK 112793D0 DK 931127 A DK931127 A DK 931127A DK 112793 A DK112793 A DK 112793A DK 112793 D0 DK112793 D0 DK 112793D0
- Authority
- DK
- Denmark
- Prior art keywords
- preparing crystalline
- crystalline type
- therapeutic medicine
- botulinium toxin
- botulinium
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
- 239000003053 toxin Substances 0.000 title 1
- 231100000765 toxin Toxicity 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4311158A JPH06192296A (ja) | 1992-10-28 | 1992-10-28 | 治療用医薬品としての結晶a型ボツリヌス毒素の製造法。 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK112793D0 true DK112793D0 (da) | 1993-10-08 |
| DK112793A DK112793A (da) | 1994-04-29 |
Family
ID=18013801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK112793A DK112793A (da) | 1992-10-28 | 1993-10-08 | Fremgangsmåde til fremstilling af krystallinsk type A botulinium toxin som et terapeutisk medikament |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPH06192296A (da) |
| DE (1) | DE4335366A1 (da) |
| DK (1) | DK112793A (da) |
| FR (1) | FR2697163B1 (da) |
| GB (1) | GB2272697A (da) |
| SE (1) | SE9303323L (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5919665A (en) | 1989-10-31 | 1999-07-06 | Ophidian Pharmaceuticals, Inc. | Vaccine for clostridium botulinum neurotoxin |
| GB9120306D0 (en) | 1991-09-24 | 1991-11-06 | Graham Herbert K | Method and compositions for the treatment of cerebral palsy |
| US8187612B2 (en) | 1993-12-28 | 2012-05-29 | Allergan, Inc. | Use of the neurotoxic component of a botulinum toxin for treating a spastic muscle |
| US8557256B2 (en) | 1993-12-28 | 2013-10-15 | Allergan, Inc. | Treatment for cervical dystonia with the neurotoxic component of a botulinum toxin |
| US6974578B1 (en) | 1993-12-28 | 2005-12-13 | Allergan, Inc. | Method for treating secretions and glands using botulinum toxin |
| NZ295998A (en) * | 1994-10-24 | 1999-10-28 | Ophidian Pharm Inc | Neutralizing antitoxins against clostridium difficile and clostidium botulinum toxins |
| JP2003009897A (ja) | 2001-07-03 | 2003-01-14 | Keiji Oguma | ボツリヌス毒素の分離・精製法 |
| RU2257914C1 (ru) * | 2004-03-31 | 2005-08-10 | Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. акад. С.Н. Федорова Министерства Здравоохранения Российской Федерации | Способ лечения паралитического косоглазия |
| CN102614264A (zh) * | 2012-05-02 | 2012-08-01 | 马守云 | 一种治疗眼脸痉挛的药物 |
| RU2535115C1 (ru) | 2013-05-15 | 2014-12-10 | Бости Трейдинг Лтд | Фармацевтический состав, содержащий нейротоксин ботулина |
| KR101775682B1 (ko) | 2015-11-30 | 2017-09-06 | 주식회사 대웅 | 보툴리눔 독소의 제조방법 |
| WO2024191217A1 (ko) | 2023-03-16 | 2024-09-19 | 주식회사 대웅 | 다중모드 크로마토그래피를 이용한 개선된 보툴리눔 독소의 정제방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR940005589B1 (ko) * | 1986-04-02 | 1994-06-21 | 다이닛뽄세이야꾸 가부시끼가이샤 | 핵산 또는 엔도톡신의 제거제 및 제거방법 |
| US5053005A (en) * | 1989-04-21 | 1991-10-01 | Gary E. Borodic | Chemomodulation of curvature of the juvenile spine |
-
1992
- 1992-10-28 JP JP4311158A patent/JPH06192296A/ja active Pending
-
1993
- 1993-10-08 DK DK112793A patent/DK112793A/da not_active Application Discontinuation
- 1993-10-11 SE SE9303323A patent/SE9303323L/ not_active Application Discontinuation
- 1993-10-16 DE DE4335366A patent/DE4335366A1/de not_active Withdrawn
- 1993-10-20 FR FR9312505A patent/FR2697163B1/fr not_active Expired - Fee Related
- 1993-10-22 GB GB9321794A patent/GB2272697A/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| SE9303323D0 (sv) | 1993-10-11 |
| FR2697163B1 (fr) | 1995-06-23 |
| SE9303323L (sv) | 1994-04-29 |
| FR2697163A1 (fr) | 1994-04-29 |
| DE4335366A1 (de) | 1994-05-05 |
| DK112793A (da) | 1994-04-29 |
| GB9321794D0 (en) | 1993-12-15 |
| GB2272697A (en) | 1994-05-25 |
| JPH06192296A (ja) | 1994-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI910389L (fi) | Foerfarande foer framstaellning av ett transdermalt terapeutiskt system med tulobuterol som aktivt aemne. | |
| DK0537971T3 (da) | Fremgangsmåde til administration af algoritme-uafhængige kryptografinøgler | |
| DK42093D0 (da) | Administrationsmetode | |
| FI914603A7 (fi) | Analogiamenetelmä lääkeaineena käyttökelpoisen pyridiinijohdannaisen valmistamiseksi | |
| DK93892A (da) | Fremgangsmaade til fremstilling af et depotpraeparat | |
| FI914398A7 (fi) | Menetelmä farmaseuttisen kokoonpanon valmistamiseksi | |
| MA22894A1 (fr) | Procede de preparation d'un vaccin. | |
| FI945465L (fi) | Menetelmä hidastetusti vapauttavien lääkevalmisteiden valmistamiseksi | |
| FI945441L (fi) | Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi | |
| DK112793D0 (da) | Fremgangsmaade til fremstilling af krystallinsk type a botulinium toxin som et terapeutisk medikament | |
| FI925633A0 (fi) | Foerfarande foer framstaellning av en farmaceutisk sammansaettning som selektivt saenker lipidnivaon i blodet | |
| NO931346L (no) | Fremgangsmaate for fremstilling av et bifenylderivat | |
| FI944052A0 (fi) | Oraalinen rokote | |
| FI961521L (fi) | Lääkeformulaatioiden valmistusmenetelmä | |
| FI941046A7 (fi) | Farmaseuttinen menetelmä | |
| DK645788A (da) | Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat | |
| DK23790A (da) | Doseringsform til administrering af en calciumantagonist | |
| NO173239C (no) | Analogifremgangsmaate til fremstilling av et terapeutisk aktivt etopodofyllotoksinglukosidacylderivat | |
| DK689188D0 (da) | Anvendelse af piperidin-derivater til fremstilling af et farmaceutisk praeparat | |
| FI913554L (fi) | Menetelmä stabiloidun farmaseuttisen koostumuksen valmistamiseksi | |
| DK158668C (da) | Hydantoinderivater, medikament indeholdende et saadant derivat, og anvendelse af et saadant derivat til fremstilling af et antiarrhytmisk medikament | |
| NO934600D0 (no) | Fremgangsmaate for dannelse av et digitalt multiplekssignal som kode-enhet for generering av et digitalt multiplekssignal | |
| DK101197A (da) | Medikament til behandling af thrombocytopenia | |
| DK0648748T3 (da) | Fremgangsmåde til fremstilling af 5-acetoacetylaminobenzimidazolon-2 | |
| DK348687D0 (da) | Fremgangsmaade til fremstilling af en terapeutisk virksom forbindelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A0 | Application filed | ||
| AHB | Application shelved due to non-payment |